{"id":"W3137607562","doi":"10.1016/j.ekir.2021.02.041","title":"Invasive Management of Coronary Artery Disease in Advanced Renal Disease","year":2021,"lang":"en","type":"review","venue":"Kidney International Reports","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Data Science Institute, Columbia University; Canada Excellence Research Chairs, Government of Canada; Janssen Scientific Affairs; Idorsia Pharmaceuticals; Siemens Medical Solutions USA; Boston Scientific Corporation; National Institute of Allergy and Infectious Diseases; OrbusNeich; Bayer; American Medical Association; Chiesi Farmaceutici; Bristol-Myers Squibb; AstraZeneca; CSL Behring; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Gilead Sciences; Medtronic; Abbott Vascular; Abbott Laboratories","keywords":"Medicine; Kidney disease; Coronary artery disease; Intensive care medicine; Disease; Population; Renal function; Randomized controlled trial; Internal medicine; Epidemiology; Cardiology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001732314,0.0004332314,0.001323182,0.0003823237,0.00002266779,0.00002306311,0.0001907489,0.0001058001,0.00125144],"category_scores_gemma":[0.00123225,0.0003960076,0.0008951343,0.00027925,0.00008199148,0.0001337019,0.000272099,0.0002616335,0.00002629124],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005452839,"about_ca_system_score_gemma":0.005118476,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005354028,"about_ca_topic_score_gemma":0.000001010348,"domain_scores_codex":[0.9965545,0.00006698762,0.001383301,0.0008069758,0.0008889203,0.0002993187],"domain_scores_gemma":[0.9966873,0.0001091318,0.0007290841,0.0008372818,0.0002039772,0.001433245],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004208088,0.002675007,0.0185629,0.08433983,0.004500217,0.2848591,0.00003496231,0.0000199411,0.000003769535,0.0009626786,0.03660292,0.5670179],"study_design_scores_gemma":[0.0008860892,0.00002905651,0.00675544,0.115382,0.002542369,0.0002747112,0.00001441649,0.000008747798,0.00000308299,0.00031612,0.8734401,0.0003478403],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005916813,0.9916784,0.000005503072,0.0003828013,0.0009775941,0.001191252,0.0006483118,0.00003705679,0.004487386],"genre_scores_gemma":[0.002478859,0.9805442,0.0001838883,0.0005121488,0.0002115743,0.0004184581,0.01210563,0.00006337822,0.003481875],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8368372,"threshold_uncertainty_score":0.9998492,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02401121940761898,"score_gpt":0.3285877433993404,"score_spread":0.3045765239917214,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}